Edwards Lifesciences Corp (EW) Options Risk Score
Real-time risk analysis for EW options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full EW options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan EW Now — Free →
Is it risky to sell options on Edwards Lifesciences Corp (EW) right now?
Edwards Lifesciences Corp (EW) currently scores 60 out of 100 for options catalyst risk (MEDIUM) over a 4-week expiry window. What pushes it there: 6 recent news items, 10 active legal filings and 19 clinical-trial catalysts, all landing inside the 4-week window. A mid-range score (45–69) means EW is neither clear nor obviously dangerous over this window — check which specific date is driving it before choosing a strike. The number reflects event exposure only.
EW shows an IV Rank of 52, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 31%. IV Rank is the most useful figure for deciding whether to sell or buy premium on EW.
EW's next earnings date is 2026-07-23, outside the near-term options window.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer